Edwards Lifesciences (EW) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 10/30/25
Exploring Analyst Estimates for Edwards Lifesciences (EW) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • 10/28/25
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EWGlobeNewsWire • 10/28/25
Successful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025Business Wire • 10/27/25
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025Business Wire • 10/27/25
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EWPRNewsWire • 10/22/25
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EWBusiness Wire • 10/16/25
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewsWire • 10/06/25
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 09/16/25
ABT vs. EW: Which Structural Heart Device Stock Is Worth Buying Now?Zacks Investment Research • 08/29/25
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease CareBusiness Wire • 08/29/25
Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law FirmGlobeNewsWire • 08/14/25
JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences AcquisitionGlobeNewsWire • 08/06/25